Gamma knife therapy is becoming more frequently applied in solid tumor treatment. This article reports a unique case of severe obstructive jaundice arising as a complication of treatment of hepatoma at the hepatic hilum using a gamma knife. While planning an intervention, some images seem to promise success but actually lead to failure. Radiation damage to specific organs is difficult to predict because of several variables. Radiation-induced fibrosis and necrosis are the most common long-term adverse effects of radiotherapy; they are usually considered irreversible and result in induration and firmness of the tissue. To minimize radiation fibrosis, accurate patient positioning and tumor relocalization are essential for gamma knife use in the liver and other extracranial sites. Even when practiced frequently, any intervention must be delivered with caution if the liver has been treated with radiation. Otherwise, even with much experience, the unwary doctor can be trapped by deceptive images.
Introduction
There have been increasing reports about gamma knife treatment of hepatoma in recent years. 1 We have managed a case of severe obstructive jaundice resulting from complications of treating hepatoma at the hepatic hilum with a gamma knife, which is rather characteristic but not previously documented. Radiation-related tissue effects resulted in fibrosis and firmness within the lobe of the liver and presented unexpected challenges to the seemingly easy draining manipulation of obstructed bile from the seriously dilated biliary tract. Care should be taken in interventions involving such lesions, which appear to promise easy success but actually lead to failure, because radiation-induced changes affect not only the primary tumor but also the adjacent, nonmalignant tissue. This presents a substantial challenge to replacement of the draining tube without tearing the structures around the liver pedicle.
Case Report
An 80-year-old woman was admitted to the local hospital with a diagnosis of cholangiocellular carcinoma at the hilus hepatis and received gamma knife treatment. Her therapeutic dose was designated as a 50% isodose line delivered in 10 fractions of 4 Gy daily, totaling 40 Gy in the periphery and 80 Gy in the center. There was no complaint in the posttreatment days. But a yellowish color was observed all over the body and sclera 3 months after the treatment and gradually became obvious thereafter.
She was referred to our hospital 4 months after the gamma knife therapy. Physical examination revealed yellow discoloration of the skin and sclera, no superficial lymphadenopathy, no cardiopulmonary abnormality, soft abdomen without tenderness, and no hepatosplenomegaly. The hepatic region was sensitive to percussion, and shifting dullness test was positive. CT examination showed granular texture of liver parenchyma without a jagged borderline, which is a sign of cirrhosis, and intrahepatic bile ducts in both the left and right lobes were obviously dilated, with lumens presenting well-demarked areas of uniformly low density, distinct from surrounding tissue ( Figure 1A ). Magnetic resonance cholangiopancreatography (MRCP) manifested intrahepatic cholangiectasis, and biliary ducts at the hilum were gathered together without a space-occupying lesion ( Figure 1B) . A blood sample study demonstrated TBIL equal to 393.2 mmol/L; DBIL, 241.6 mmol/L; IBIL, 151.6 mmol/L; TBA, 86.8 mmol/L; GGT, 553 IU/L; ALP, 369 IU/L; AST, 187 IU/L; ALT, 127 IU/L; AFP, 7.70 ng/mL; CEA, 7.24 ng/mL; and CA 19-9, > 1000 IU/mL. No contraindications to interventional therapy were found. Percutaneous transhepatic cholangiography and drainage (PTCD) were selected for biliary decompression and tissue protection. The puncture site was determined in the 9th intercostal space along the right midaxillary line, under local anesthesia. A PTCD set (Boston Scientific, USA) was picked. A 21 gauge needle was inserted into the skin toward the xyphoid direction. When bile was seen in the withdrawing syringe, contrast was injected for radiography. A portion of the right hepatic duct was found to be dilated like a sac, whereas other biliary ducts and the common bile duct were not seen in the radiogram (Figure 2A ). A guide wire was introduced for progressively expanding the pierced passage. Tissue around the needle path turned out to be surprisingly stiff and the passage proved resistant to dilation, such that the 5F dilator failed to get into the needle path at its furthest attempt. Any exertion with modest force would have markedly displaced the liver toward the midline, producing an interspace greater than 10 cm in width between the outer surface of the organ and the internal abdominal wall and excluding the possibility of further dilation. The procedure of PTCD was suspended to avoid laceration of structures around the liver pedicle by forceful pushing and to protect the patient under local anesthesia from the painful and stressful experience of continuous handling. Another PTCD was carried out 5 days later with general anesthesia. The needle was inserted into the left hepatic duct from below the xyphoid. Contrast radiography revealed remarkable expansion of the entire left hepatic duct, and segmental ducts were irregular in size, tortuously distorted, and structurally deformed. A small amount of contrast entered the duodenum but not the right hepatic duct ( Figure 2B ). Resistance to dilation was strikingly decreased compared with that encountered in the previous attempt. After gradual dilation, an 8F external drainage tube was passed through the passageway with enough flexibility. Resistance force greater than usual was encountered during passage dilation and tube insertion, and induration of tissue near the hilum was sensed. The amount of daily drained bile through the tube was 100 mL. On reexamination of the liver function 2 weeks after the procedure, we found the following: TBIL, 335.3 mmol/L; DBIL, 237.6 mmol/L; IBIL, 97.7 mmol/L; GGT, 89 IU/L; ALP, 205 IU/L; AST, 52 IU/L; ALT, 30 IU/L. Impaired liver function improved and jaundice was relieved.
Discussion
The gamma knife was first used for intracranial tumor treatment 2 and has recently been assigned extracranial use and subsequently been named stereotactic body radiotherapy. 3 It has the advantage of treating well-demarcated targeted tissues with very large doses of radiation in a single fraction or a few fractions with the intent of causing profound late tissue damage within the targeted volume. However, considerable effort must be taken to reduce nontarget tissue exposure to the high dose levels in order to prevent late complications in involved organs. 4 A few trials using the gamma knife have been reported with the liver, with several documented toxicities, including liver failure, infection, elevation of transferase, asthenia, and portal hypertension with melena. 5 Radiation damage to specific organs is difficult to predict because of factors such as the use of intensity-modulated beams, nonuniform dose distributions, partial organ irradiation, and interpatient and even intraorgan variations in radiation sensitivity. 6 Experimental gamma knife radiosurgery 7 suggested fibrocyte-myofibroblastic cell transformation in the vessel wall, which might contribute to vessel occlusion and tumor shrinkage. Radiation-induced fibrosis and necrosis are the most common long-term adverse effects of radiotherapy and are usually considered irreversible 8 and account for the endurance and firmness of the tissue near the irradiation route.
Our patient manifested biliary obstruction and absence of tumor at the hilum, an indication for PTCD. The right hepatic duct was seriously distended and closer to the body surface, and the large and heavy right lobe was not easily overpenetrated, so the route to the right was taken for the sake of safety and success. The tissue of the right liver turned out to be unexpectedly firm and resulted in the dilating force being ineffective for the needle path but threatening to tear the liver pedicle and surrounding structures. The manipulator intended to ensure safety, only to find that this route made access difficult-being neither safe nor helpful in reaching the goal-and therefore had to suspend the effort. Both CT and MRCP displayed signs of biliary ducts converging into the hilum, which could have resulted from the compression of biliary ducts by radiation-induced fibrosis and necrosis, not from obstruction by tumor growth. Such compression also caused the interruption of the connection between the left and right hepatic ducts, leading to absence of other biliary ducts and the common bile duct in the radiogram wherein the portion of the right hepatic duct was visualized.
For the next attempt, we chose a route in the anterioposterior oblique direction for PTCD. The liver was pushed by the puncture force to rest tightly against the right lateral abdominal wall, in a position that made it relatively immobile and unchangeable, accounting for the successful dilation. The patient had been irradiated to the right. Therefore, the right lobe had received the most gamma rays and had become firm because of severe fibrosis, whereas the left lobe had been less irradiated and had less severe fibrosis, which facilitated dilation of the needle path. For safety, 9 general anesthesia was prescribed to prevent the patient from feeling pain and trauma and also to keep her breath slow and rhythmic. Another point that contributed to the success was that the anesthesiologist assisted the operator in especially monitoring vital signs.
The unexpected firmness of the right lobe was not a consequence of intrahepatic tumor progression. CT and MRCP images showed either dilated or constricted bile ducts but neither compression nor destruction of the bile duct wall, which are common signs of intrahepatic tumor growth. Nor were mass lesions found in liver tissue. Furthermore, on puncturing, it is usually easy to insert the needle in the tumor tissue and easy to dilate because it is loose and rather soft with abundant vasculature and does not have the firmness observed in our case.
For biologically equivalent single and fractionated doses of radiotherapy, the pathophysiological mechanisms of radiation-induced normal tissue damage are similar. 10 In addition, imaging by CT or MRI overestimates the true gross pathological size of hepatoma in most instances. 11 And CT during arterial portography frequently and significantly overestimates the size of malignant hepatic tumors, even compared with equilibrium phase CT. 12 Other factors, including body position and respiration of the patient, also affect therapeutic efficacy and increase toxicity to the neighborhood. Such pitfalls must be taken into account to reduce impairment of normal tissue. Optimal dose fractionation schemes for hepatoma have to be found for the gamma knife. To minimize radiation fibrosis, accurate patient positioning and tumor relocalization are essential for gamma knife use in the liver and other extracranial sites. Use of 4-dimensional CT images 13 is helpful for motion tracking and aids spatial accuracy and also helps avoid planning-target-volume enlargement. 14 Although PTCD is a common practice, it must be delivered with caution if the liver has been treated with irradiation, Otherwise, even with long experience, the unwary doctor can be trapped by deceptive images.
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